Clinical Trial Update: A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial studied whether JNJ-38518168 affects methotrexate plasma levels in people with rheumatoid arthritis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-38518168
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED